AcquisitionOther
Sigilon Therapeutics, Inc. acquired Sigilon Therapeutics INDIANAPOLIS
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Sigilon Therapeutics, Inc. -> Sigilon Therapeutics INDIANAPOLIS · $4.06
"By combining Sigilon's talent and expertise in cell therapy with the knowledge and skills of Lilly's research and development teams, we will enhance opportunities to create innovative islet cell therapy solutions to improve the care of people living with diab
Open source record (SEC) ↗